Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John F Dillon

Showing results (11-20 of 176) with videos related to

Pageof 18
Sort By:
Diagnostics (Basel, Switzerland)|January 28, 2021
Identifying the Hidden Population: Former Intravenous Drug Users Who Are No Longer in Contact with Services. "Ask a Friend"Sarah R Donaldson, Andrew Radley, John F Dillon
Harm Reduction Journal|January 15, 2025
Future destinations: how people cured of hepatitis C using direct acting antiviral drugs progress in a new HCV-free world. A thematic analysisSarah R Donaldson, Andrew Radley, John F Dillon
Journal of Clinical and Translational Hepatology|October 28, 2022
Reactive Oxygen Species and Oxidative Stress in the Pathogenesis of MAFLDKathleen Clare, John F Dillon, Paul N Brennan
European Journal of Gastroenterology & Hepatology|November 8, 2014
A systematic review of the prevalence of mildly abnormal liver function tests and associated health outcomesSven Radcke, John F Dillon, Aja L Murray
Touchreviews in Endocrinology|January 25, 2023
Advances and Emerging Therapies in the Treatment of Non-alcoholic SteatohepatitisPaul N Brennan, John F Dillon, Rory McCrimmon
BMJ Open|February 8, 2022
Transformation of identity in substance use as a pathway to recovery and the potential of treatment for hepatitis C: a systematic review protocolSarah R Donaldson, Andrew Radley, John F Dillon
Clinical Interventions in Aging|December 19, 2022
How to Effectively Monitor Aging Patients with Chronic Hepatitis B: A ReviewChan Keat Kang, Paul N Brennan, John F Dillon
Current Hepatology Reports|September 1, 2017
Genetic Factors Influencing Drug-Induced Liver Injury: Do They Have a Role in Prevention and Diagnosis?Kathleen E Clare, Michael H Miller, John F Dillon
BMJ Open Gastroenterology|October 14, 2015
Systematic review of genetic association studies involving histologically confirmed non-alcoholic fatty liver diseaseKayleigh L Wood, Michael H Miller, John F Dillon
Hepatology, Medicine and Policy|October 6, 2018
Urgent action to fight hepatitis C in people who inject drugs in EuropeJohn F Dillon, Jeffrey V Lazarus, Homie A Razavi
Pageof 18

Showing results (11-20 of 176) with videos related to

Sort By:
Pageof 18
Diagnostics (Basel, Switzerland)|January 28, 2021
Identifying the Hidden Population: Former Intravenous Drug Users Who Are No Longer in Contact with Services. "Ask a Friend"Sarah R Donaldson, Andrew Radley, John F Dillon
Harm Reduction Journal|January 15, 2025
Future destinations: how people cured of hepatitis C using direct acting antiviral drugs progress in a new HCV-free world. A thematic analysisSarah R Donaldson, Andrew Radley, John F Dillon
Journal of Clinical and Translational Hepatology|October 28, 2022
Reactive Oxygen Species and Oxidative Stress in the Pathogenesis of MAFLDKathleen Clare, John F Dillon, Paul N Brennan
European Journal of Gastroenterology & Hepatology|November 8, 2014
A systematic review of the prevalence of mildly abnormal liver function tests and associated health outcomesSven Radcke, John F Dillon, Aja L Murray
Touchreviews in Endocrinology|January 25, 2023
Advances and Emerging Therapies in the Treatment of Non-alcoholic SteatohepatitisPaul N Brennan, John F Dillon, Rory McCrimmon
BMJ Open|February 8, 2022
Transformation of identity in substance use as a pathway to recovery and the potential of treatment for hepatitis C: a systematic review protocolSarah R Donaldson, Andrew Radley, John F Dillon
Clinical Interventions in Aging|December 19, 2022
How to Effectively Monitor Aging Patients with Chronic Hepatitis B: A ReviewChan Keat Kang, Paul N Brennan, John F Dillon
Current Hepatology Reports|September 1, 2017
Genetic Factors Influencing Drug-Induced Liver Injury: Do They Have a Role in Prevention and Diagnosis?Kathleen E Clare, Michael H Miller, John F Dillon
BMJ Open Gastroenterology|October 14, 2015
Systematic review of genetic association studies involving histologically confirmed non-alcoholic fatty liver diseaseKayleigh L Wood, Michael H Miller, John F Dillon
Hepatology, Medicine and Policy|October 6, 2018
Urgent action to fight hepatitis C in people who inject drugs in EuropeJohn F Dillon, Jeffrey V Lazarus, Homie A Razavi
Pageof 18